ESLAW ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM)
- 0.091
- 0.0000.00%
3：首次持股声明-董事 Zhang Hong
ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM) | SC 13D：超过5%持股股东披露文件-Eureka Therapeutics, Inc.(71.8%)
ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM) | 3：首次持股声明-首席财务官 Xu Jiandong
ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM) | 3：首次持股声明-董事 Roberts Marsha
ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM) | 3：首次持股声明-董事 Xu Pei
ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM) | 3：首次持股声明-首席执行官 Liu Cheng
ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM) | 3：首次持股声明-董事 Wu Xuejun Janelle
ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM) | 3：首次持股声明-董事 Wu Fan
ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM) | 3：首次持股声明-股东 Eureka Therapeutics, Inc.
ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM) | 4：持股变动声明-股东 Owl Creek Asset Management, L.P.